- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT03203278
Web-based Exercise for South Asian People With Type 2 Diabetes
Web-based Exercise Intervention for South Asian People With Type 2 Diabetes: a Randomised Controlled Trial
Přehled studie
Postavení
Podmínky
Intervence / Léčba
Detailní popis
A mixed method approach involving both qualitative and quantitative methods will be used.
The quantitative component will consist of a single blind, randomised controlled trial (RCT), which will explore the effects of the intervention on glycaemic control (blood sugar levels) and other secondary outcomes.
The qualitative component will consist of face to face interviews to explore the views of participants regarding acceptability and barriers affecting adherence to this intervention.
Potential participants will be informed about the study at hospital diabetes clinics, community health organisations, support groups, places of worship and General Practitioner (GP) surgeries. Recruitment is estimated to last for 9 months. Potential participants will be sent a participant information sheet (PIS) in either English or Urdu, depending on their preference. Those wishing to take part will meet the researcher at a convenient location, for eligibility screening and consent. If necessary, translation services can be arranged for those with limited English throughout the study.
Following baseline assessment, participants will be randomised to either the intervention or control group. Participants in the control group will be asked to continue their usual care and day to day physical activity routine. In addition, they will be given general information about diabetes management. Participants who wish to use the website for exercise will be provided with access at the end of all assessments.
Participants assigned to the intervention group will be asked to perform a personalised exercise programme, undertaken three times a week (with no more than two rest days between sessions) for 12 weeks. Participants will meet the researcher face to face immediately after randomisation. During this meeting, a brief physical assessment will be undertaken and exercise goals will be discussed and agreed with participants. The researcher will then design a personalised exercise programme for each participant using the resources available on the web-based exercise website. The exercise programme prescription and progression will be in line with American Diabetes Association (ADA) and American College of Sports Medicine (ACSM) guidelines (Colberg et al. 2016). The website (www.webbasedphysio.com) will be used to deliver the intervention. This website has been modified, in collaboration with South Asians, to be culturally suitable for people of South Asian backgrounds in terms of content and language (Albalawi et al, under review). The researcher will contact participants every two weeks via telephone to encourage use of the website, ask about progress, and to deal with any technical issues that they might face while using the website. Participants will be advised to contact the researcher to request a change in their programme or if a problem arises. The researcher will make changes remotely and participants will be informed of any changes by phone or email. Participants will be asked to meet the researcher face to face to discuss progression and goals at week 6 (midway). Regardless of groups allocation, all participants will be assessed three times by a blind assessor at baseline (week=0) , after the end of the intervention (week=12) and 8 weeks after the end of the intervention (week=20).
Assessment of outcome measures will take place at convenient locations and each visit should take no more than 90 minutes. Travel expenses will be provided.
All participants will be informed that they are free to withdraw from the study at any time without being obliged to give notice or provide any explanation. Any data collected before their withdrawal will be considered in the analysis.
Typ studie
Zápis (Aktuální)
Fáze
- Nelze použít
Kontakty a umístění
Studijní místa
-
-
-
Glasgow, Spojené království
- NHS Greater Glasgow and Clyde
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Popis
Inclusion Criteria:
- define themselves as South Asians
- BMI 21 - 29.9 kg/m2
- diagnosed with Type 2 Diabetes Mellitus (T2DM) by a physician more than 6 months previously
- access to a personal computer/tablet, smart phone or smart television with an email address and Internet connection
- able to understand English or Urdu
Exclusion Criteria:
- type 1 diabetes
- any medical conditions that would affect adherence or contraindicate exercise including severe peripheral neuropathy, severe autonomic neuropathy, severe physical limitations, heart disease, pre-proliferative or proliferative retinopathy, uncontrolled hypertension (>180/ 100mmHg), or coronary artery disease.
- people using insulin if they do not have a self-monitoring glucose device or are unable to use such devices.
- engaging in exercise training of 150 minutes a week or more
- participating in other interventional studies aiming to improve glycaemic control
- unwilling to be randomised
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Léčba
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Singl
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Žádný zásah: Kontrolní skupina
Obvyklá péče
|
|
|
Experimentální: Web-based exercise programme
Personalised exercise programme, undertaken three times a week (with no more than two rest days between sessions) for 12 weeks
|
Aerobic, resistance and balance exercises
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Glycaemic control
Časové okno: Baseline to 12 weeks
|
Change in HbA1c
|
Baseline to 12 weeks
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Blood lipid profile (cholesterol)
Časové okno: Baseline to 12 weeks
|
Change in total cholesterol level
|
Baseline to 12 weeks
|
|
Blood lipid profile (cholesterol)
Časové okno: 12 weeks to 20 weeks
|
Change in total cholesterol level
|
12 weeks to 20 weeks
|
|
Blood lipid profile (high density lipoproteins)
Časové okno: Baseline to 12 weeks
|
Change in high density lipoprotein (HDL) level
|
Baseline to 12 weeks
|
|
Blood lipid profile (high density lipoproteins)
Časové okno: 12 weeks to 20 weeks
|
Change in high density lipoprotein (HDL) level
|
12 weeks to 20 weeks
|
|
Blood lipid profile (low-density lipoproteins)
Časové okno: Baseline to 12 weeks
|
Change in low density lipoprotein (LDL) level
|
Baseline to 12 weeks
|
|
Blood lipid profile (low-density lipoproteins)
Časové okno: 12 weeks to 20 weeks
|
Change in low density lipoprotein (LDL) level
|
12 weeks to 20 weeks
|
|
Blood lipid profile (triglyceride)
Časové okno: Baseline to 12 weeks
|
Change in triglyceride level
|
Baseline to 12 weeks
|
|
Blood lipid profile (triglyceride)
Časové okno: 12 weeks to 20 weeks
|
Change in triglyceride level
|
12 weeks to 20 weeks
|
|
Blood pressure
Časové okno: Baseline to 12 weeks
|
Change in blood pressure result
|
Baseline to 12 weeks
|
|
Blood pressure
Časové okno: 12 weeks to 20 weeks
|
Change in blood pressure result
|
12 weeks to 20 weeks
|
|
Body mass index (BMI)
Časové okno: Baseline to 12 weeks
|
Change in BMI
|
Baseline to 12 weeks
|
|
Body mass index (BMI)
Časové okno: 12 weeks to 20 weeks
|
Change in BMI
|
12 weeks to 20 weeks
|
|
Waist circumference
Časové okno: Baseline to 12 weeks
|
Change in waist circumference
|
Baseline to 12 weeks
|
|
Waist circumference
Časové okno: 12 weeks to 20 weeks
|
Change in waist circumference
|
12 weeks to 20 weeks
|
|
Ten metre walking test (10MWT)
Časové okno: Baseline to 12 weeks
|
Change in 10 MWT result
|
Baseline to 12 weeks
|
|
Ten metre walking test (10MWT)
Časové okno: 12 weeks to 20 weeks
|
Change in 10 MWT result
|
12 weeks to 20 weeks
|
|
Timed Up and Go test
Časové okno: Baseline to 12 weeks
|
Change in Timed Up and Go test result
|
Baseline to 12 weeks
|
|
Timed Up and Go test
Časové okno: 12 weeks to 20 weeks
|
Change in Timed Up and Go test result
|
12 weeks to 20 weeks
|
|
Muscle power
Časové okno: Baseline to 12 weeks
|
Change in hand grip dynamometer score
|
Baseline to 12 weeks
|
|
Muscle power
Časové okno: 12 weeks to 20 weeks
|
Change in hand grip dynamometer score
|
12 weeks to 20 weeks
|
|
Quality of Life - WHO-QOL BREF score
Časové okno: Baseline to 12 weeks
|
Change in World Health Organisation Quality of Life (WHO-QOL BREF) score
|
Baseline to 12 weeks
|
|
Quality of Life - WHO-QOL BREF score
Časové okno: 12 weeks to 20 weeks
|
Change in World Health Organisation Quality of Life (WHO-QOL BREF) score
|
12 weeks to 20 weeks
|
|
Adherence - exercise diary completion
Časové okno: 12 weeks
|
Number of times exercise diary completed
|
12 weeks
|
|
Dietary intake
Časové okno: Baseline to 12 weeks
|
Change in Food Frequency Questionnaire score
|
Baseline to 12 weeks
|
|
Dietary intake
Časové okno: 12 weeks to 20 weeks
|
Change in Food Frequency Questionnaire score
|
12 weeks to 20 weeks
|
|
Change in Medication
Časové okno: Baseline to 12 weeks
|
Change in medication
|
Baseline to 12 weeks
|
|
Change in Medication
Časové okno: 12 weeks to 20 weeks
|
Change in medication
|
12 weeks to 20 weeks
|
|
Glycaemic control
Časové okno: 12 weeks to 20 weeks
|
Change in HbA1c
|
12 weeks to 20 weeks
|
Spolupracovníci a vyšetřovatelé
Sponzor
Spolupracovníci
Vyšetřovatelé
- Ředitel studie: Lorna Paul, PhD, Glasgow Caledonian University
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Aktuální)
Primární dokončení (Aktuální)
Dokončení studie (Aktuální)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Klíčová slova
Další relevantní podmínky MeSH
Další identifikační čísla studie
- GN17DI329
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .
Klinické studie na Diabetes mellitus, typ 2
-
Korea United Pharm. Inc.Zatím nenabíráme
-
Helen Keller Eye Research FoundationFive Lakes Clinical Research Consulting, LLCNáborSticklerův syndrom typu 2 | Sticklerův syndrom typu 1Spojené státy
-
Izmir Bakircay UniversityDokončenoDiabetes mellitus, typ 2 | Diabetes Mellitus, typ 2 léčený inzulínemTurecko (Türkiye)
-
Hoffmann-La RocheDokončenoDiabetes 2. typu, Diabetes 1. typuRakousko, Spojené království
-
Griffin HospitalCalifornia Walnut CommissionDokončenoDIABETES MELLITUS TYP 2Spojené státy
-
Services Hospital, LahoreDokončeno
-
Universite du Quebec en OutaouaisUniversity Hospital, Angers; McGill University; Centre de Recherche du Centre...Zatím nenabírámeDiabetes mellitus, typ 1 | Diabetes, autoimunita | Diabetes typu 2 | Diabetes; Nástup v dospělostiKanada
-
Zhejiang Provincial People's HospitalShandong Suncadia Medicine Co., Ltd.Nábor
-
Fujifilm Medical Systems USA, Inc.International HealthCare, LLCZatím nenabírámeRutinní screeningová mamografie
-
University of Roma La SapienzaNeznámýDiabetes Mellitus Typ 2 Reaktivita krevních destiček StatinItálie